Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · IEX Real-Time Price · USD
24.63
-0.32 (-1.28%)
At close: May 1, 2024, 4:00 PM
24.13
-0.50 (-2.03%)
After-hours: May 1, 2024, 6:51 PM EDT
Surgery Partners Revenue
In the year 2023, Surgery Partners had annual revenue of $2.74B with 8.03% growth. Revenue in the quarter ending December 31, 2023 was $735.40M with 4.00% year-over-year growth.
Revenue (ttm)
$2.74B
Revenue Growth
+8.03%
P/S Ratio
1.14
Revenue / Employee
$203,207
Employees
13,500
Market Cap
3.12B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.74B | 204.00M | 8.03% |
Dec 31, 2022 | 2.54B | 314.20M | 14.12% |
Dec 31, 2021 | 2.23B | 365.00M | 19.62% |
Dec 31, 2020 | 1.86B | 28.70M | 1.57% |
Dec 31, 2019 | 1.83B | 59.90M | 3.38% |
Dec 31, 2018 | 1.77B | 626.06M | 54.66% |
Dec 31, 2016 | 1.15B | 185.55M | 19.33% |
Dec 31, 2015 | 959.89M | 556.60M | 138.02% |
Dec 31, 2014 | 403.29M | 118.69M | 41.70% |
Dec 31, 2013 | 284.60M | 24.38M | 9.37% |
Dec 31, 2012 | 260.22M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch Health Companies | 8.76B |
Evolent Health | 1.96B |
LivaNova | 1.15B |
Progyny | 1.09B |
Sotera Health Company | 1.05B |
HUTCHMED (China) | 838.00M |
TransMedics Group | 241.62M |
IDEAYA Biosciences | 23.39M |
SGRY News
- 13 days ago - Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details - GlobeNewsWire
- 5 weeks ago - Surgery Partners, Inc. Announces Pricing of New Senior Notes Offering - GlobeNewsWire
- 5 weeks ago - Surgery Partners, Inc. Announces New Senior Notes Offering - GlobeNewsWire
- 2 months ago - Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2023 Results; Sets 2024 Guidance - GlobeNewsWire
- 2 months ago - Surgery Partners, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details - GlobeNewsWire
- 3 months ago - Sheridan Capital Partners-Backed Oral Surgery Partners Announces $400M Credit Expansion, Multiple Acquisitions, and C-Suite Hires - Business Wire
- 4 months ago - Surgery Partners, Inc. Reaffirms 2023 Full Year Guidance and Provides 2024 Initial Adjusted EBITDA Outlook - GlobeNewsWire
- 4 months ago - Surgery Partners, Inc. to Present at Upcoming Investor Conference - GlobeNewsWire